Dana-Farber study finds that oncologists differ widely on offering cancer gene testing

Dana-Farber study finds that oncologists differ widely on offering cancer gene testing A study by researchers at Dana-Farber Cancer Institute shows that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients’ tumor samples, while others plan to offer this type of cancer gene testing to most of … Continue reading “Dana-Farber study finds that oncologists differ widely on offering cancer gene testing”

Dana-Farber study finds that oncologists differ widely on offering cancer gene testing

A study by researchers at Dana-Farber Cancer Institute shows that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients’ tumor samples, while others plan to offer this type of cancer gene testing to most of their patients.

Click here to read the full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply